Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Intangibles (2020 - 2025)

Biofrontera has reported Intangibles over the past 6 years, most recently at $2.6 million for Q4 2025.

  • For Q4 2025, Intangibles rose 7471.43% year-over-year to $2.6 million; the TTM value through Dec 2025 reached $2.6 million, up 7471.43%, while the annual FY2025 figure was $2.6 million, 7471.43% up from the prior year.
  • Intangibles for Q4 2025 was $2.6 million at Biofrontera, up from $22000.0 in the prior quarter.
  • Over five years, Intangibles peaked at $3.6 million in Q3 2021 and troughed at $22000.0 in Q3 2025.
  • A 5-year average of $2.1 million and a median of $2.6 million in 2025 define the central range for Intangibles.
  • On a YoY basis, Intangibles climbed as much as 7471.43% in 2025 and fell as far as 98.94% in 2025.
  • Year by year, Intangibles stood at $3.4 million in 2021, then dropped by 12.12% to $3.0 million in 2022, then fell by 13.29% to $2.6 million in 2023, then tumbled by 98.67% to $35000.0 in 2024, then surged by 7471.43% to $2.6 million in 2025.
  • Business Quant data shows Intangibles for BFRI at $2.6 million in Q4 2025, $22000.0 in Q3 2025, and $26000.0 in Q2 2025.